Beyond Medical Technologies Inc Stock Price, News & Analysis

Republic Technologies (CSE: DOCT) has announced a strategic partnership with FalconX, a digital asset prime brokerage, to support its Ethereum validator operations. The partnership will provide ETH liquidity and execution support for Republic's validator infrastructure, which is essential for its attestation services platform.

The company is developing an attestation platform that will enable enterprises to issue and verify digital proofs on the Ethereum blockchain. To power this system, Republic is establishing an ETH-denominated treasury and will utilize FalconX's institutional-grade trading infrastructure, liquidity solutions, and risk management expertise.

The collaboration aims to ensure efficient and compliant deployment of ETH treasury into validator operations as Republic transitions from development to commercial deployment.

Republic Technologies (CSE: DOCT) has announced the adoption of an Advance Notice Policy effective September 4, 2025. The policy establishes formal procedures for shareholders nominating directors to the Board, requiring advance notice of 30 days prior to annual general meetings, or 10 days if the meeting is announced less than 50 days in advance.

Additionally, the company has engaged Machai Capital Inc. for digital marketing services in a one-month contract valued at $50,000 plus GST. The marketing campaign is set to launch in September 2025. Machai's principal, Mr. Suneal Sandhu, currently holds 200,000 common shares and 300,000 warrants of Republic Technologies.

Republic Technologies (CSE: DOCT) held its Annual General and Special Meeting of Shareholders on August 19, 2025, where shareholders approved all proposed matters. The company's shareholders elected four directors to the board: Daniel Liu, Hongming Luo, Tianrui Zhang, and Litong Cao.

Additionally, shareholders appointed Charlton & Company, CPA as the company's auditor and approved a new 20% rolling long-term incentive plan. The meeting also resulted in the approval of deleting and replacing the Company's Articles, which are available on SEDAR+.

Republic Technologies (CSE: DOCT) has announced a strategic partnership with BitGo Trust Company to secure its Ethereum operations and digital asset treasury. BitGo, a leading digital asset infrastructure provider, offers regulated custody services across 90+ countries with up to $250 million in insurance coverage for cold storage assets.

The partnership will enable Republic to leverage BitGo's custody-integrated staking infrastructure for generating rewards on ETH treasury assets while maintaining assets in segregated cold storage. BitGo's infrastructure is certified under SOC 1 Type 2 and SOC 2 Type 2 standards, providing institutional-grade security and regulatory compliance.

Republic Technologies (CSE: DOCT) has announced a strategic integration with Kraken, a leading digital asset exchange, to enhance its Ethereum infrastructure operations. The partnership will support Republic's attestation and validator operations through Kraken's institutional infrastructure.

Kraken, established in 2011, operates in over 190 countries with regulatory oversight across multiple jurisdictions and maintains SOC 2 Type II certification. Republic will utilize Kraken's platform to streamline treasury deployment for its validator operations, which are crucial for their proprietary attestation platform that generates on-chain proofs for data verification in decentralized systems.

Beyond Medical Technologies (CSE: DOCT) has announced its corporate name change to Republic Technologies Inc., effective July 15th, 2025. The company's common shares will maintain their trading symbol "DOCT" on the Canadian Securities Exchange, with a new CUSIP (760801100) and ISIN (CA7608011002).

Republic Technologies focuses on developing smart contract-based attestation products and operating Ethereum validators through ETH staking. The company maintains ETH as its primary treasury asset and aims to expand its holdings alongside infrastructure growth. The new name reflects the company's commitment to decentralization, transparency, and democratized access to secure systems.

Beyond Medical Technologies (OTC:DOCKF) reported significant progress in H1 2025 and announced its transformation into Republic Technologies, positioning itself to become Canada's first public company integrating Ethereum infrastructure as a core operational component.

Key developments include: raising CAD $3.45 million through various financings, launching a dedicated treasury division for ETH management, and securing strategic partnerships with BitGo and Fireblocks for digital asset custody. The company has expanded its attestation platform beyond healthcare to support sector-agnostic use cases and is preparing to launch its Early-Access Attestation Dashboard for enterprise clients.

The company's transformation includes adopting Ethereum infrastructure for its platform operations, treasury strategy, and validator infrastructure, aligning with major institutions like BlackRock, PayPal, and JPMorgan Chase.

Beyond Medical Technologies (OTC: DOCKF) has received acceptance from the British Columbia Securities Commission (BCSC) for its management cease trade order (MCTO) application. The MCTO, effective May 1, 2025, relates to a delay in filing the company's 2024 annual financial statements and related documentation. The delay is attributed to a recent management team transition. The company expects to complete the Annual Filings by June 30, 2025 and will comply with alternative information guidelines, including bi-weekly default status updates.

Beyond Medical Technologies (CSE: DOCT, OTC: DOCKF) has announced it will likely miss the April 30, 2025 deadline for filing its annual financial statements and related documents for the fiscal year ended December 31, 2024. The company has applied for a Management Cease Trade Order (MCTO) with the British Columbia Securities Commission due to delays caused by a recent management team transition.

The company expects to complete the Annual Filings by June 30, 2025. During the MCTO period, public trading of shares will continue, but company executives and certain insiders will be restricted from trading. Beyond Medical will issue bi-weekly status updates and comply with alternative information guidelines under National Policy 12-203.